SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Tidefelt Ulf 1951 )
 

Search: WFRF:(Tidefelt Ulf 1951 ) > Expression of topoi...

  • Uggla, Bertil,1962-Department of Medicine, Örebro Medical Center Hospital, Örebro, Sweden (author)

Expression of topoisomerase IIalpha in the G0/G1 cell cycle phase of fresh leukemic cells

  • Article/chapterEnglish2001

Publisher, publication year, extent ...

  • Oxford, United Kingdom :Elsevier,2001
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:oru-49518
  • https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-49518URI
  • https://doi.org/10.1016/S0145-2126(01)00062-5DOI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:1956194URI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Topoisomerase IIalpha (topoII alpha) is the target enzyme for several antineoplastic drugs. Correlation between low expression of topo IIalpha and drug resistance has been shown in vitro, but there is limited evidence of a correlation to initial response to treatment or to overall prognosis. Normal cells express topo IIalpha in S/G2/M phase of the cell cycle but not in G0/G1 phase. However, some data suggest that topo IIalpha could be expressed in G0/G1 phase in malignant cells. We have investigated the expression of topo IIalpha in leukemic cells from 25 patients with acute leukemia by flow cytometry, separating cells of different cell cycle phases. We demonstrated that 9/25 samples showed >50% positive cells in G0/G1, and another five samples showed >20%. This finding could possibly provide an explanation to previous difficulties in correlating topo IIalpha expression with clinical outcome. Six of eight patients, where >20% of the cells in G0/G1 were positive for topo IIalpha, entered CR, compared to one of five patients with <20% topo IIalpha positive cells in G0/G1. We suggest that topo IIalpha expression in G0/G1 in leukemic cells may be of predictive value for clinical response to cytostatic drugs.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Möllgård, LarsKarolinska Institutet (author)
  • Ståhl, ElisabethDepartment of Pathology, Örebro Medical Center Hospital, Örebro, Sweden (author)
  • Mossberg, Lise-Lott MossbergDepartment of Pathology, Örebro Medical Center Hospital, Örebro, Sweden (author)
  • Karlsson, Mats G.,1960-Department of Pathology, Örebro Medical Center Hospital, Örebro, Sweden(Swepub:oru)mskn (author)
  • Paul, ChristerKarolinska Institutet (author)
  • Tidefelt, Ulf,1951-Department of Medicine, Örebro Medical Center Hospital, Örebro, Sweden; Karolinska Institute, Stockholm, Sweden(Swepub:oru)uftt (author)
  • Karolinska InstitutetDepartment of Medicine, Örebro Medical Center Hospital, Örebro, Sweden (creator_code:org_t)

Related titles

  • In:Leukemia ResearchOxford, United Kingdom : Elsevier25:11, s. 961-9660145-21261873-5835

Internet link

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view